Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Army
Farmers Insurance
Cipla
Johnson and Johnson
AstraZeneca
Baxter
US Department of Justice
UBS

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062751

« Back to Dashboard

NDA 062751 describes C-SOLVE-2, which is a drug marketed by Fougera Pharms and Ivax Sub Teva Pharms and is included in two NDAs. Additional details are available on the C-SOLVE-2 profile page.

The generic ingredient in C-SOLVE-2 is erythromycin. There are one hundred and two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062751
Tradename:C-SOLVE-2
Applicant:Ivax Sub Teva Pharms
Ingredient:erythromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 062751

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SWAB;TOPICALStrength2%
Approval Date:Jul 30, 1993TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Johnson and Johnson
US Army
Medtronic
Covington
AstraZeneca
Citi
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.